About-Manning/IALS Innovation Grants
Manning/IALS Innovation Grants
The Manning/IALS Seed Grants are part of the Manning/IALS Innovation Program. These translational grants are designed to advance applied R&D efforts from UMass-based faculty research groups through the development of spin-out/startup companies and the out-licensing of UMass intellectual property.
Alumnus Paul Manning and his wife, Diane, committed $1 million through their family foundation to establish the Manning Innovation Program. The gift provides three years of support in advancing a robust and sustainable commercialization pipeline of applied and translational research projects from UMass Amherst.
2022 Award Winners
- Hasentech – Barbara Osborne and Lisa Minter, veterinary and animal sciences, College of Natural Sciences, A Novel Cell-Based Therapy for Graft-versus-Host Disease
- ISight – Murugappan Muthukumar, polymer science and engineering, College of Natural Sciences, Curing and Preventing Cataracts and Presbyopia Without Surgery
- Latde – Sloan Siegrist, microbiology, College of Natural Sciences, Rapid, Low-cost Diagnostic for Bloodborne Bacterial Infections
- Marieb-IV – Karen Giuliano and Juan Jimenez, Elaine Marieb College of Nursing, mechanical and industrial engineering, College of Engineering, A Novel IV Pole to Improve the Safety of IV Medication Administration During Acute Care Hospitalization
- NaturaFloc – Chul Park, civil and environmental engineering, College of Engineering, Low Cost, Enhanced Auto-Clarification in Wastewater Treatment
- Optical Waters – Mariana Lopes, civil and environmental engineering, College of Engineering, Germicidal Optical Fibers to Prevent Disease-causing Biofilms in Endoscopes
2021 Award Winners
- 3Daughters: Carlos Gradil, Veterinary & Animal Sciences. A Women’s Healthcare startup developing a new ergonomic, pain-free, magnetic intrauterine device (IUD).
- E2-PATH: Karen Dunphy/Joe Jerry, Veterinary & Animal Sciences. A diagnostic personalized medicine screening platform for selecting optimized breast cancer treatments.
- OPG Wastewater Treatment: Chul Park, Civil & Environmental Engineering. Developing technology that enables aeration-free and energy efficient wastewater treatment.
- Optical Waters: Mariana Lopes, Civil & Environmental Engineering. Germicidal Optical Fibers to Prevent Disease Causing Biofilms in Medical Devices
- RNA4Therapeutics: Craig Martin, Chemistry. A novel manufacturing technology for the synthesis of high purity, low-cost, and large scale RNA manufacturing for therapeutic use.
- Volvox Sciences: Ashish Kulkarni, Chemical Engineering. Developing a novel supramolecular nano-therapeutic (CSF-SNT) that can efficiently remove cancer tumor cells.
2020 Award Winners
- Barbara Osborne, Veterinary and Animal Sciences, “Developing Novel Therapeutics to Treat Inflammatory Bowel Disease by a Bacterial Exopolysaccharides”.
- David Julian McClements, Food Sciences, “Nutriply – a start-up developing probiotics in gummy form, making them easier to use”.
- Sloan Siegrist, Microbiology, for “Developing a diagnostic for detecting blood-borne pathogenic bacteria (sepsis)”
- Neil Forbes, Chemical Engineering, to “Demonstrate efficacy of a novel bacterial therapeutic - EBT-302 - for treatment of liver cancer” for start-up Ernest Pharmaceuticals.
- Amir Arbabi, Electrical and Computer Engineering, to develop “Metasurface-enabled miniature LIDAR systems” for robotics, automatic guided vehicles, and integration into smartphones.
- James Allan, Computer Sciences, to develop software tools aimed at “Explaining contradictory claims in the biomedical/healthcare domain”.
2019 Award Winners
- Derek Lovley, microbiology, “Fabricating Protein Nanowires for Unique Sensing Capabilities”
- Jeanne Hardy, chemistry, “Development of Potent Zika Virus Protease Inhibitors”
- S. “Thai” Thayumanavan, chemistry, and Steve Faraci, “Pre-Clinical efficacy evaluation of liver-targeted, thyromimetic-encapsulated IntelliGels for the treatment of non-alcoholic steatohepatitis (NASH)”
- Neil St. John Forbes, chemical engineering, “Bacterial delivery of therapeutic peptides to treat advanced hepatocellular carcinoma (HCC)"
- Shelly Peyton, chemical engineering, “GelTech” to enable tissue-specific drug discovery and help eliminate potential false-positive hits from screening"
- Madalina Fiterau Brostean, computer science, “4Thought: Unlocking Insights into Your Mental Health”
Significant funding for this opportunity comes from a gift by the Manning Family Foundation and from the Institute for Applied Life Sciences (IALS) Seed Fund Program. Recipients of Manning funds will be designated Manning/IALS Innovation Fellows.
Administration of the Manning/IALS Innovation Awards is managed through IALS with oversight from the IALS Executive Committee - Deans of College of Natural Sciences, College of Engineering, School of Public Health & Health Sciences, Elaine Marieb College of Nursing, Manning College of Information & Computer Sciences, the Vice Chancellor of Research and Engagement, and the Provost. Contact us at firstname.lastname@example.org.